1. [P3–173]: ZCCHC17 IMPAIRMENT IS A SIGNIFICANT DRIVER OF NEURONAL DYSFUNCTION IN ALZHEIMER's DISEASE. (1st July 2017) Authors: Tomljanovic, Zeljko; Patel, Mitesh; Argyrousi, Elentina; Teich, Andrew Franklin Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 21 Page Start: P1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PDE5 inhibitors against synaptic and cognitive impairment in Alzheimer's disease and related dementia. (20th December 2022) Authors: Arancio, Ottavio; Zuccarello, Elisa; Fiorito, Jole; Acquarone, Erica; Argyrousi, Elentina; Staniszewski, Agnieszka; Calcagno, Elisa; Puzzo, Daniela; Deng, Shi‐Xian; Landry, Donald Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗